BIOLIFE SOLUTIONS INC — Director's Dealing 2019

Nov 30, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2019-11-26

Reporting Person: Mathers James (Vice President, Global Sales)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-26	Common Stock	M	2500	$1.64	Acquired	19884	Direct
2019-11-26	Common Stock	S	2500	$16.52	Disposed	17384	Direct
2019-11-27	Common Stock	M	2500	$1.64	Acquired	19884	Direct
2019-11-27	Common Stock	S	2500	$16.27	Disposed	17384	Direct
2019-11-29	Common Stock	M	2500	$1.64	Acquired	19884	Direct
2019-11-29	Common Stock	S	2500	$16.33	Disposed	17384	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-11-26	Employee Stock Option	$1.64	M	2500	Disposed	2021-12-20	Common Stock (2500)	Direct
2019-11-27	Employee Stock Option	$1.64	M	2500	Disposed	2021-12-20	Common Stock (2500)	Direct
2019-11-29	Employee Stock Option	$1.64	M	2500	Disposed	2021-12-20	Common Stock (2500)	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.50 to $16.56, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.23 to $16.30, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.26 to $16.40, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range